<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pmj</journal-id><journal-title-group><journal-title xml:lang="ru">Тихоокеанский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Pacific Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1609-1175</issn><publisher><publisher-name>TGMU</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.34215/1609-1175-2019-4-74-77</article-id><article-id custom-type="elpub" pub-id-type="custom">pmj-389</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCHES</subject></subj-group></article-categories><title-group><article-title>Влияние кардиореабилитации на силу кистей рук, мышечную массу и дистанцию ходьбы у мужчин среднего возраста в зависимости от дебюта ишемической болезни сердца</article-title><trans-title-group xml:lang="en"><trans-title>The influence of cardiac rehabilitation on the muscular strenght of the hand flexors, muscle mass and walking distance in middle-aged men, depending on the onset of coronary heart disease</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4688-0739</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ефремушкина</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Efremushkina</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ефремушкина Анна Александровна – доктор медицинских наук, профессор кафедры терапии и общей врачебной практики с курсом дополнительного профессионального образования врачей AГМУ</p><p>656038, Барнаул, пр-т Ленина, 40</p></bio><bio xml:lang="en"><p>Anna A. Efremishkina, MD, PhD, professor, Department of Therapy and General Medical Practice, ASMU</p><p>40 Lenina Ave., Barnaul, 656038</p></bio><email xlink:type="simple">sunsun3@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кожедуб</surname><given-names>Я. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kozhedub</surname><given-names>Ya. A.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Суворова</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Suvorova</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Алтайский государственный медицинский университет;&#13;
Алтайский краевой кардиологический диспансер</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Altai State Medical University;&#13;
Altai Regional Cardiological Clinic</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Алтайский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Altai State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Алтайский краевой кардиологический диспансер</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Altai Regional Cardiological Clinic</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>28</day><month>12</month><year>2019</year></pub-date><volume>0</volume><issue>4</issue><fpage>74</fpage><lpage>77</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ефремушкина А.А., Кожедуб Я.А., Суворова А.А., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Ефремушкина А.А., Кожедуб Я.А., Суворова А.А.</copyright-holder><copyright-holder xml:lang="en">Efremushkina A.A., Kozhedub Y.A., Suvorova A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.tmj-vgmu.ru/jour/article/view/389">https://www.tmj-vgmu.ru/jour/article/view/389</self-uri><abstract><sec><title>Цель</title><p>Цель: оценка влияния кардиореабилитации (КР) в виде ходьбы под самоконтролем у мужчин среднего возраста с различным дебютом ишемической болезни сердца (ИБС) на силу кистей рук, мышечную массу и дальность 6-минутной ходьбы.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Обследованы 90 мужчин 45–65 лет с одинаковой давностью ИБС с различными дебютами: инфаркт миокарда (ИМ) – 56 человек, или стенокардия напряжения – 34 человека. После 9-месячной КР оценивали мышечную силу сгибателей кисти (МССК), проводили биоимпедансометрию и тест 6-минутной ходьбы, определяли уровень тестостерона в сыворотке крови.</p></sec><sec><title>Результаты</title><p>Результаты. У пациентов с дебютом ИБС в виде ИМ МССК увеличилась в среднем с 43 до 49 ДаН на правой и с 41 до 46 ДаН – на левой руке, долевое соотношение мышечной ткани возросло с 48,4 до 48,8 %, расстояние 6-минутной ходьбы – с 450 до 500 м. У пациентов с дебютом ИБС в виде стенокардии напряжения доля мышечной ткани уменьшилась с 48,2 до 47,3 %, дальность 6-минутной ходьбы – с 405 до 400 м без достоверной динамики МССК.</p></sec><sec><title>Заключение</title><p>Заключение. 9-месячная КР у пациентов после ИМ оказывала позитивный эффект на МССК, мышечную ткань и выносливость при ходьбе, в отличие от пациентов со стенокардией напряжения.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective: The objective is to assess the influence of cardiac rehabilitation (CR), represented by self-controlled walking in middleaged men with different onsets of coronary heart disease (CHD), on the muscular strength of the hand flexors, muscle mass and 6-minute walking distance.</p></sec><sec><title>Methods</title><p>Methods: 90 men aged from 45 to 65 with the same prescriptive CHD with different onsets: myocardial infarction (MI) – 56 patients, or stable angina – 34 patients were examined. After 9 months of CR we have assessed the muscular strength of the hand flexors (MSHF), have run the bioelectrical impedance analysis and 6-minute walking test, have determined the level of testosterone in blood serum.</p></sec><sec><title>Results</title><p>Results: In patients with CHD with MI as an onset, MSHF of the right hand increased from 43 to 49 DAN at the average, and from 41 to 46 DAN – of the left hand; equity proportion of muscle tissue increased from 48.4 to 48.8% , 6-minute walking distance – from 450 to 500 meters. In patients with CHD with stable angina as an onset, the proportion of muscle tissue decreased from 48.2 to 47.3 %, 6-minute walking distance – from 405 to 400 meters without significant improvement of MSHF.</p></sec><sec><title>Conclusions</title><p>Conclusions: 9-month CR in patients after MI had a positive effect on MSHF, muscle tissue and stamina as opposed to the patients with stable angina.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>инфаркт миокарда</kwd><kwd>стенокардия напряжения</kwd><kwd>мышечная сила сгибателей кисти</kwd><kwd>биоимпедансометрия</kwd><kwd>кардиореабилитация</kwd></kwd-group><kwd-group xml:lang="en"><kwd>6-минутная ходьба</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Cooper R, Hardy R. Objectively measured physical capability levels and mortality: Systematic review and meta-analysis. BMJ. 2010;341:44–67.</mixed-citation><mixed-citation xml:lang="en">Cooper R, Hardy R. Objectively measured physical capability levels and mortality: Systematic review and meta-analysis. BMJ. 2010;341:44–67.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Leong DP, Teo KK, Rangarajan S, Lopes-Jaramillo P, Avezum Jr A, Orlandini A, et al. Prognostic value of grip strength: Findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet. 2015;386(9990):266–73.</mixed-citation><mixed-citation xml:lang="en">Leong DP, Teo KK, Rangarajan S, Lopes-Jaramillo P, Avezum Jr A, Orlandini A, et al. Prognostic value of grip strength: Findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet. 2015;386(9990):266–73.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Калиниченко С.Ю., Тюзиков И.А. Практическая андрология. М.: Практическая медицина, 2009. 399 с.</mixed-citation><mixed-citation xml:lang="en">Kalinichenko SYu, Tyuzikov IA. Practical andrology. Moscow: Practical Medicine; 2009. 399 p. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases. 1987;40(5):373–83.</mixed-citation><mixed-citation xml:lang="en">Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases. 1987;40(5):373–83.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Бубнова М.Г., Аронов Д.М. Обеспечение физической активности граждан, имеющих ограничение в состоянии здоровья: методические рекомендации. Кардиосоматика. 2016;7(1):5–50.</mixed-citation><mixed-citation xml:lang="en">Bubnova MG, Aronov DM. Ensuring the physical activity of citizens who have a restriction in the state of health: Methodological recommendations. Journal of Cardiosomatics. 2016;7(1):5–50. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kim JH, Lim S, Choi SH, Kim KM, Yoon JW, Kim KW, et al. Sarcopenia: An independent predictor of mortality in communitydwelling older Korean men. The Journal of Gerontology: Series A. 2014;69(10):1244–52.</mixed-citation><mixed-citation xml:lang="en">Kim JH, Lim S, Choi SH, Kim KM, Yoon JW, Kim KW, et al. Sarcopenia: An independent predictor of mortality in communitydwelling older Korean men. The Journal of Gerontology: Series A. 2014;69(10):1244–52.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Gupta S, Rohatgi A, Ayers CR, Willis BL, Haskell WL, Khera A, et al. Cardiorespiratory fitness and classification of risk of cardiovascular disease mortality. Circulation. 2011;123:1377–83.</mixed-citation><mixed-citation xml:lang="en">Gupta S, Rohatgi A, Ayers CR, Willis BL, Haskell WL, Khera A, et al. Cardiorespiratory fitness and classification of risk of cardiovascular disease mortality. Circulation. 2011;123:1377–83.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Dallan L, Jatene FB. Myocardial revascularization in the XXI century. Revista Brasileira de Cirurgia Cardiovascular. 2013; 28(1):137–44.</mixed-citation><mixed-citation xml:lang="en">Dallan L, Jatene FB. Myocardial revascularization in the XXI century. Revista Brasileira de Cirurgia Cardiovascular. 2013; 28(1):137–44.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention &amp; Rehabilitation (EACPR). European Heart Journal. 2016;37(29): 2315–81.</mixed-citation><mixed-citation xml:lang="en">Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention &amp; Rehabilitation (EACPR). European Heart Journal. 2016;37(29): 2315–81.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Kishimoto H, Hata J, Ninomiya T, Nemeth H, Hirakawa Y, Yoshida D, et al. Midlife and late-life handgrip strength and risk of cause-specific death in a general Japanese population: The Hisayama Study. Journal of Epidemiology &amp; Community Health. 2014;68:663–8.</mixed-citation><mixed-citation xml:lang="en">Kishimoto H, Hata J, Ninomiya T, Nemeth H, Hirakawa Y, Yoshida D, et al. Midlife and late-life handgrip strength and risk of cause-specific death in a general Japanese population: The Hisayama Study. Journal of Epidemiology &amp; Community Health. 2014;68:663–8.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
